Genomic and transcriptomic landscape of HER2-low breast cancer.

Saved in:
Bibliographic Details
Title: Genomic and transcriptomic landscape of HER2-low breast cancer.
Authors: Bansal R; Duke Cancer Institute, Duke University Hospital, 20 Medicine Circle, Durham, NC, 27710, USA. rani.bansal@duke.edu., Adeyelu T; Caris Life Sciences, Phoenix, AZ, USA., Elliott A; Caris Life Sciences, Phoenix, AZ, USA., Walker P; Caris Life Sciences, Phoenix, AZ, USA., Bustos MA; Saint John's Cancer Institute, Santa Monica, CA, USA., Rodriguez E; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA., Accordino MK; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Meisel J; Emory Winship Cancer Center, Atlanta, GA, USA., Gatti-Mays ME; The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, USA., Hsu E; Legorreta Cancer Center at Brown University, Providence, RI, USA., Lathrop K; UT Health San Antonio, San Antonio, TX, USA., Kaklamani V; UT Health San Antonio, San Antonio, TX, USA., Oberley M; Caris Life Sciences, Phoenix, AZ, USA., Sledge G; Caris Life Sciences, Phoenix, AZ, USA., Sammons SL; Dana Farber Cancer Institute, Boston, MA, USA., Graff SL; Legorreta Cancer Center at Brown University, Providence, RI, USA. sgraff1@lifespan.org.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jan; Vol. 209 (2), pp. 323-330. Date of Electronic Publication: 2024 Sep 20.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7217
DOI:10.1007/s10549-024-07495-4